Dr. Chen Pak Lam Sammy - Pathology
Specialist in Pathology
Highlights
- MCHK RegisteredVerified
- Specialist in PathologyBachelor of Medicine and Bachelor of Surgery (MBBS) · The Hong Kong College of Pathologists · Medical degree 2003
- InsuranceBeing compiled｜See details
About
Dr. Chen Pak Lam Sammy is a registered Pathology specialist in Hong Kong.
Education
Specialist in Pathology
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)2003
Hong Kong Academy of Medicine fellowships
- FHKCPathFellow, The Hong Kong College of Pathologists
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Chen Pak Lam Sammy? Claim page and update insurance →
FAQ
Is Dr. Chen Pak Lam Sammy any good?
Dr. Chen Pak Lam Sammy is a registered Pathology specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Chen Pak Lam Sammy do?
Dr. Chen Pak Lam Sammy practises in Pathology.
Are you Dr. Chen Pak Lam Sammy? Claim this page to update and manage.
ClaimResearch and publications
15 papers · 12 most recent shown
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- COPeptin Evaluation in argininevasopressin Deficiency post transsphenoidal surgery (COPED study).Pituitary · 2026
- Acquired 11β-Hydroxylase deficiency in etomidate and (Iso)propoxate abusers: A nascent endocrine condition.Steroids · 2025
- Acquired 11β-hydroxylase Deficiency by Inhaled Etomidate and its Analogues: A Mimic of Congenital Adrenal Hyperplasia.JCEM case reports · 2024
- A Chinese girl with delayed puberty due to 17α-hydroxylase deficiency: the diagnosis, treatment and monitoring approach.Endocrinology, diabetes & metabolism case reports · 2023
- Hyperammonemia in a girl who inherited a likely pathogenic variant of the ornithine transcarbamylase gene from her asymptomatic father-A peculiar pattern of X-linked recessive inheritance.Clinical case reports · 2022
- Denosumab versus alendronate in long-term glucocorticoid users: A 12-month randomized controlled trial.Bone · 2021
- In-house multiplex ligation-dependent probe amplification assay for citrin deficiency: analytical validation and novel exonic deletions in SLC25A13.Pathology · 2021
- Case Report: The first familial hCG syndrome in a Chinese family.F1000Research · 2021
- Nephrogenic syndrome of inappropriate antidiuresis - An ethnically, genetically and phenotypically diverse disorder: First report in a Chinese adult and review of published cases.Clinica chimica acta; international journal of clinical chemistry · 2021
- Toxicity from illegitimate slimming agents - a 10-year case series at a tertiary toxicology laboratory in Hong Kong.Clinical toxicology (Philadelphia, Pa.) · 2021
- Determination of cerebrospinal fluid adenosine deaminase activity cut-off for the diagnosis of tuberculous meningitis in Hong Kong.Journal of clinical pathology · 2020
- Case Report: The first probable Hong Kong Chinese case of <i>LPIN1</i>-related acute recurrent rhabdomyolysis in a boy with two novel variants.F1000Research · 2019
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer